Reina Takeda¹, Shuhei Asada¹, Daichi Inoue², Tomofusa Fukuyama¹, Susumu Goyama¹, Toshio Kitamura¹ (1.Division of Cellular Therapy, IMSUT, Tokyo, Japan, 2.Memorial Sloan Kettering Cancer Center, New York, USA)

Taishi Yonezawa¹, Hirotaka Takahashi², Tatsuya Sawasaki², Toshio Kitamura¹, Susumu Goyama¹ (1.The institute of Medical Science., Tokyo Univ., Tokyo, Japan, 2.Proteo-Science Center (PROS)., Ehime University., Ehime, Japan)

Yasuhiko Kamikubo (Human Health Sciences., Kyoto Univ., Grad. Sch. Med)

Yusuke Nakauchi¹, Daniel Thomas¹, Rajiv Sharma¹, Ryan Corces¹, Andreas Reinisch¹, David Hernandez¹, Thomas Koehnke¹, Daiki Karigane¹, Amy Fan¹, Daniel Martinezkrams¹, John Cao², Lucy Godley², Ravindra Majeti¹ (1.Hematol., Stanford Univ., Stanford, USA, 2.Hematol./Oncol., Univ. Chicago, Chicago, USA)

Takuji Yamauchi^1,2, Kohta Miyawaki¹, Yuichiro Semba¹, Fumihiko Nakao¹, Takeshi Sugio^1,2, Kensuke Sasaki¹, Junpei Nogami¹, Schoonenberg Vivien³, Cole Mitchel³, Trevino Claudio³, Yao Qiuming³, Canver Matthew³, Osborne Simon⁴, Pinello Luca⁵, Taylor Debbie⁴, Bauer Daniel³, Koichi Akashi¹, Takahiro Maeda² (1.Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, 2.Center for Cellular Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan, 3.Boston Children Hospital/Harvard Medical School, Boston, USA, 4.LifeArc, WC1H 9LT, London, United Kingdom, 5.Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA)

Yoshitaka Sunami^1,2, Takuro Nakamura¹ (1.Division of Carcinogenesis, The Cancer institute of JFCR, Tokyo, Japan, 2.Department of Hematology, Juntendo University, Tokyo, Japan)